Modification of the Cutaneous Dermatomyositis Disease Area and Severity Index, an outcome instrument

Ítems similars

• Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositis
  per: Klein, RQ, et al.
  Publicat: (2008)
• Validation of the Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI): characterizing disease severity and assessing responsiveness to clinical change
  per: Anyanwu, C.O., et al.
  Publicat: (2015)
• The validity and utility of the Cutaneous Disease Area and Severity Index (CDASI) as a clinical outcome instrument in dermatomyositis: a comprehensive review
  per: Ahmed, S., et al.
  Publicat: (2020)
• The Cutaneous Lupus Erythematosus Disease Area and Severity Index: A Responsive Instrument to Measure Activity and Damage in Patients With Cutaneous Lupus Erythematosus
  per: Bonilla-Martinez, Zuleika L., et al.
  Publicat: (2008)
• The CLASI (Cutaneous LE Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus
  per: Albrecht, Joerg, et al.
  Publicat: (2005)